Dr. Edward T. O'brien

John T. Comerci, MD, is a surgical oncologist, director of Gynecologic Oncology at UPMC Passavant Hospital, and associate professor at the University of Pittsburgh School of Medicine. His expertise is in robotic surgery and the diagnosis and management of diseases of the female reproductive organs, including ovarian, uterine, cervical, and vulvar cancers. His research interests include photodynamic therapy in the treatment of cervical and ovarian cancer. Dr. Comerci is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Testicular Yolk Sac Tumor, and Vulvectomy.

Dr. Ramdin is a board-certified and fellowship-trained cancer physician specializing in medical oncology and hematology. She attended the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, where she earned her medical degree. She completed her residency at Roger Williams Medical Center, and completed her fellowship in hematology/oncology at Rhode Island Hospital. Dr. Ramdin is certified by the American Board of Internal Medicine. Dr. Ramdin is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, and Adenoid Cystic Carcinoma.

Joshua Kesterson, MD, is a fellowship-trained gynecologic oncologist and medical director of the gynecologic oncology program at UPMC in Central Pa. He received his medical degree from the University of Missouri and completed his residency in obstetrics, gynecology and women’s health at the University of Louisville, followed by his fellowship in gynecologic oncology at Roswell Park Cancer Institute. He is board-certified in obstetrics and gynecology and gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Kesterson’s clinical interests include gynecologic oncology such as ovarian, cervical, and endometrial cancer, immunotherapy, and HPV, and his research interests include quality improvement, ovarian cancer, and endometrial carcinoma. He is a member of the Society for Gynecologic Oncologists, the Foundation for Women’s Cancer, and Alpha Omega Alpha Honor Society. Dr. Kesterson is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor.